- About
- PsychU For You
- Topics
- Events
- Content
Virtual Event – Strategies to Optimize Patient Outcomes In Bipolar I Disorder
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Strategies to Optimize Patient Outcomes In Bipolar I Disorder
This is a Virtual Event for PsychU members in Connecticut, New Jersey, and New York.
Bipolar I Disorder is characterized by mood episode recurrence, which impacts patient functioning and clinical outcomes.1,2 During our discussion, Drs. Alyssa Weers and Jehan Marino, along with featured speaker, Dr. Joseph Goldberg, will discuss risk factors for mood recurrence including non-adherence. They will also discuss some management strategies including long acting injectables (LAIs) that may optimize patient outcomes.
Objectives:
- Understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes
- Discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder
- Review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder
References:
- Vaquez GH European Neuropsychopharmacology 2015; 25: 1501-1512
- Kapczinski NS, et al. Expert Rev Neurother. 2017;17(3):277-285
Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai
MoreJoseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois, and medical school at Northwestern University. He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 200 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications, 2nd edition” published in 2019 by American Psychiatric Publishing, and the forthcoming “Practical Psychopharmacology” by Cambridge University Press. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly’s “America’s Top Doctors.”
Jehan Marino, PharmD, BCPP
Medical Science Director
Alyssa Weers, PharmD (OPDC)
Clinical & Scientific Liaison
Speaker Joseph Goldberg, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speakers Jehan Marino, PharmD, BCPP and Alyssa Weers, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.Related Events
Registration
- PsychU For You
